Work

A Phase II, single-center, single-arm study evaluating the safety and efficacy of golidocitinib in the management of newly diagnosed PTCL (GOLDEN Study)

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-5434

Authors: Eduardo Edelman Saul, Jessie Xu, Casey Bermack, Cathrine Paras, Jared Henderson, Kristofer Jennings, Bryan Valcarcel, Dr. Mohammad Abdul-Jaber Abdulla, Luis Fayad, Hun Lee, Preetesh Jain, Ranjit Nair, Michael Wang, Swami Iyer, Christopher Flowers, Luis Malpica

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417016924

Cites:

Cited by:

Related to: